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Abstract
Background
Leptospirosis is an important but neglected bacterial zoonosis that has been largely over-
looked in Africa. In this systematic review, we aimed to summarise and compare current
knowledge of: (1) the geographic distribution, prevalence, incidence and diversity of acute
human leptospirosis in Africa; and (2) the geographic distribution, host range, prevalence
and diversity of Leptospira spp. infection in animal hosts in Africa.
Methods
Following Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA)
guidelines, we searched for studies that described (1) acute human leptospirosis and (2)
pathogenic Leptospira spp. infection in animals. We performed a literature search using
eight international and regional databases for English and non-English articles published
between January 1930 to October 2014 that met out pre-defined inclusion criteria and strict
case definitions.
Results and Discussion
We identified 97 studies that described acute human leptospirosis (n = 46) or animal Lep-
tospira infection (n = 51) in 26 African countries. The prevalence of acute human leptospiro-
sis ranged from 2 3% to 19 8% (n = 11) in hospital patients with febrile illness. Incidence
estimates were largely restricted to the Indian Ocean islands (3 to 101 cases per 100,000
per year (n = 6)). Data from Tanzania indicate that human disease incidence is also high in
mainland Africa (75 to 102 cases per 100,000 per year). Three major species (Leptospira
borgpetersenii, L. interrogans and L. kirschneri) are predominant in reports from Africa and
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isolates from a diverse range of serogroups have been reported in human and animal infec-
tions. Cattle appear to be important hosts of a large number of Leptospira serogroups in
Africa, but few data are available to allow comparison of Leptospira infection in linked
human and animal populations. We advocate a ‘One Health’ approach to promote multidis-
ciplinary research efforts to improve understanding of the animal to human transmission of
leptospirosis on the African continent.
Author Summary
Leptospirosis is an important bacterial zoonosis that affects people and animals world-
wide. It is common in tropical areas where people and animals live in close contact, but
the disease has been widely neglected in Africa. In this study we aimed to demonstrate the
extent of leptospirosis in Africa and describe the diversity of the causative agent Leptospira
spp. in human and animal infections across the continent. Through a systematic literature
review, we identified 97 studies from 26 African countries that described human disease or
animal infection and met inclusion criteria. Leptospirosis was the cause of illness in 2 3%
to 19 8% of hospital patients with a fever. Where population-level data were available, lep-
tospirosis was estimated to affect 3 to 102 people per 100,000 every year. A variety of ani-
mal hosts of Leptospira spp. were identified. Cattle were reported as carriers of a variety of
serological types of Leptospira spp. infection. The role of cattle and many other different
animal hosts in human disease transmission remains unclear. Our review demonstrates
that leptospirosis is a substantial cause of human illness in Africa, and we recommend
integration of human and animal studies in the future to help us understand the epidemi-
ology of leptospirosis on this continent.
Introduction
Endemic zoonotic diseases affect impoverished and developing communities worldwide but
are frequently overshadowed in public and clinician awareness by high profile infections such
as malaria and HIV/AIDS [1, 2]. In Africa, zoonotic infections are both directly responsible for
human illness and death and indirectly impact human well-being as a result of reduced live-
stock productivity and food security [3–5]. However, bacterial zoonoses including leptospirosis
remain under-diagnosed and under-reported in Africa, and as a result are overlooked as public
health priorities [1, 2, 6].
Leptospirosis is one of the most common and widespread zoonotic infections in the world
and is recognised as a neglected disease by the World Health Organisation (WHO) [7]. Human
leptospirosis is caused by infection with pathogenic strains of Leptospira spp. bacteria [8, 9].
More than 250 pathogenic Leptospira serovars are known to exist worldwide, which are classi-
fied into 25 serogroups on the basis of their serological phenotype [10, 11]. Recent species
determination by DNA homology has identified 13 pathogenic Leptospira spp., and seven of
these (L. interrogans, L. borgpetersenii, L. santarosai, L. noguchii, L. weilli, L. kirschneri and
L. alexanderi) are considered as the foremost agents of human and animal disease [10, 12].
Both serological and DNA-based classification systems are currently in use for clinical diagno-
sis and in understanding the pathogenesis and epidemiology of the disease [11, 13, 14].
A wide range of animals can carry pathogenic Leptospira bacteria and act as a source of
infection [8, 11]. Leptospira serovars often demonstrate a degree of animal host preference and
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some common relationships between serovars and their hosts are reported [9, 15]. Following
infection, the bacteria colonise the renal tubules and urogenital tract and are shed in the urine
of infected animals. Animal species may be asymptomatic carriers of infection (maintenance
hosts) or develop clinical disease (accidental hosts) depending on the infecting serovar [11, 16].
In food producing animals, cattle and pigs are relatively susceptible to clinical infection result-
ing in production losses including reduced milk yield, reproductive failure and abortions
[16, 17].
In people, disease occurs through direct or indirect contact with infected urine from an ani-
mal host [8, 9, 15]. Good knowledge of Leptospira serovars circulating in local animal popula-
tions is important to determine sources and transmission routes for human infection [8]. In
the early stages, human leptospirosis manifests most commonly as a non-specific febrile illness
that is hard to distinguish from other aetiologies of febrile disease particularly in tropical areas
[11, 18, 19]. Infection can result in severe secondary sequelae including renal failure and pul-
monary haemorrhagic syndrome, and a case fatality ratio of up to 50% has been reported in
complicated cases [15, 19].
Leptospirosis is particularly common in the tropical areas where people and animals live in
close contact, and warm and humid conditions favour environmental survival and transmission
of the pathogen [8, 9]. In South-East Asia and South America, leptospirosis is recognised as an
important cause of renal failure and febrile disease [18–22]. However, despite its global impor-
tance, large gaps persist in our knowledge of the burden and epidemiology of leptospirosis in
Africa. Reports from theWHO Leptospirosis Epidemiology Reference Group (LERG) indicate
that leptospirosis incidence may be high in Africa, but also highlight the lack of available data [7,
23]. Although reported seroprevalence data demonstrates widespread exposure to Leptospira
spp. in humans and animals in Africa, [24] little is known about the extent of human disease or
the epidemiology of Leptospira infection in different animal species in Africa.
To tackle these gaps in current understanding and awareness of human and animal Leptos-
pira infection in Africa, we performed a systematic review of peer-reviewed and grey literature
following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA)
guidelines [25]. Our aims were summarise and compare: (1) current knowledge of the geo-
graphic distribution, prevalence, incidence and diversity of acute human leptospirosis in
Africa; and (2) the geographic distribution, host range, prevalence and diversity of Leptospira
spp. infection in animal hosts in Africa.
Methods
Search strategy
A detailed protocol for this study can be found in the supplementary material (S1 File). Follow-
ing the PRISMA guidelines and checklist (S1 Checklist) references for this review were identi-
fied through searches of eight international and regional databases (Table 1) using the search
string ‘Leptospirosis’ OR ‘Leptospira’ and ‘Africa’ for articles published between January 1930
and October 2014 inclusively. Additional articles for inclusion were identified by bibliography
hand searches of relevant articles [26].
Study selection and criteria
Abstracts and titles were compiled in EndNote (Thomson Reuters, Philadelphia, PA, USA) and
reviewed independently by two researchers (KJA, HMB) to determine whether each article met
pre-determined abstract inclusion and exclusion criteria (S1 File). A third researcher (JEBH)
served as a tiebreaker for any discordant decisions. Citations were included if they presented
data on human or animal Leptospira spp. infection from any country within the United
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Nations (UN) definition of Africa [27]. We excluded abstracts that did not refer to original
human or animal leptospirosis research data, or did not describe naturally occurring cases of
leptospirosis in human or animal populations. We included case reports but excluded reports
of returned travellers because of potential uncertainty around the specific location where infec-
tion was acquired.
Articles classified as eligible for inclusion were retrieved in full text format and assessed
against pre-defined case definitions (Table 2) of human acute leptospirosis and carrier animal
status agreed upon by three authors (KJA, HMB, JEBH). Rigorous diagnostic criteria were speci-
fied in accordance withWHO and international reference laboratory guidelines (Table 2) [7, 11,
16]. Serological diagnostics were not included in the case definition for carrier animals because
of the inability to differentiate between previous exposure and current infection status. We also
excluded articles describing studies that used laboratory animal inoculations as a diagnostic test
for leptospirosis because of concerns over the risk of false positive results as a consequence of
pre-existing infection in experimental animal colonies, diagnostic sensitivity and cross-contami-
nation [16]. Full text articles were reviewed by two authors (KJA, HMB) and were excluded if
they failed to meet case definitions, if results from the same cohort were presented more compre-
hensively in another eligible article, or if insufficient information was provided in the study
methodology to determine whether the case definitions were met. Non-English language articles
identified for full text review (n = 97) included French language articles translated by KJA with
assistance from a native language speaker (n = 83); German language articles translated by a
native language speaker (n = 7); Italian articles translated by a native language speaker (n = 4);
Afrikaans (n = 2) and Dutch language articles (n = 1), which were translated using online trans-
lation software with support from a Dutch language speaker [28].
Data extraction and synthesis
Two reviewers (KJA, HMB) independently extracted pre-determined qualitative and
quantitative data from each included article. Data on infection prevalence and incidence for
Table 1. Full search strategies for database searches (in alphabetical order).
Database Publication Date
Limits
Search Strategies
Africa-Index Medicus (World Health
Organization Global Health Library)
January
1930-October 2014
(Leptospirosis OR Leptospira)
Africa-Wide:NiPAD (now EBSCO Host
Africa Wide Information)
January
1930-October 2014
(SU (leptospirosis OR leptospira) OR TX (leptospirosis OR leptospira)) AND (AB
Africa* OR GE africa OR SU africa OR TI Africa* OR KW africa)
BIOSIS Previews January
1930-October 2014
Search 1: Topic = (leptospirosis) OR Topic = (leptospira) OR title = (leptospirosis)
OR title = (leptospira); Search 2: topic = (Africa*) OR title = (Africa*); Search 3:
Combine Search 1 AND Search 2
CAB International: CAB abstracts and
Global Health
January
1930-October 2014
Search 1: Topic = (leptospirosis) OR Topic = (leptospira) OR title = (leptospirosis)
OR title = (leptospira); Search 2: topic = (Africa*) OR title = (Africa*); Search 3:
Combine Search 1 AND Search 2
Embase (Ovid; including Embase Classic
and Embase)
January
1947-October 2014
((leptospirosis [sh] OR leptospira [sh] OR leptospirosis [tw] OR leptospira [tw]) AND
(africa*[sh] OR africa*[tw]))
Pubmed January
1930-October 2014
((leptospirosis[mesh] OR leptospirosis[Text Word] OR leptospira[Text Word] OR
leptospira[mesh)) AND (africa[mesh] OR africa*[Text Word]))
Web of Science Core Collection January
1930-October 2014
Search 1: Topic = (leptospirosis) OR Topic = (leptospira) OR title = (leptospirosis)
OR title = (leptospira); Search 2: topic = (Africa*) OR title = (Africa*); Search 3:
Combine Search 1 AND Search 2
Zoological Record January
1930-October 2014
Search 1: Topic = (leptospirosis) OR Topic = (leptospira) OR title = (leptospirosis)
OR title = (leptospira); Search 2: topic = (Africa*) OR title = (Africa*); Search 3:
Combine Search 1 AND Search 2
doi:10.1371/journal.pntd.0003899.t001
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comparable studies (i.e. similar study inclusion criteria and diagnostic methodologies) were
compiled, and ranges were presented by study type (human studies), location or host species
(animal studies) if three or more citations reporting comparable data were identified. Data on
serological and genetic typing of leptospiral isolates from people and animals were compiled
and summarised by country and by animal species. Additional data on serogroup and genetic
species of reported serovars was obtained from the Leptospirosis Library, maintained by the
Leptospirosis Reference Centre, Royal Tropical Institute (KIT), Netherlands [29].
Critical assessment of methodological quality and bias
The risk of bias in included studies such as selection or reporting bias was assessed following
the Cochrane guidelines for systematic reviews of medical interventions [30]. Full text study
validity and methodological quality was assessed by comparison to pre-determined case defini-
tion criteria to control for heterogeneity in study design and diagnostic methodology (Table 2).
Studies classified as high-risk for bias were not included in quantitative analysis of leptospirosis
prevalence and incidence data.
Results
Our searches yielded 681 unique articles from a total of 1201 abstracts identified by database
searches. Data can be accessed through: http://dx.doi.org/10.5525/gla.researchdata.191. After
abstract and full text review, 95 citations published between 1956 and 2014 were eligible for
inclusion. Hand searches identified two additional articles that met inclusion criteria but were
not identified in the original database search. Reasons for full-text exclusion are detailed in
Fig 1. In total we included 97 articles that described human or animal studies conducted in 26
Table 2. Case definitions for study inclusion: Acute human leptospirosis and confirmed animal car-
rier hosts.
Human acute disease case deﬁnition, conﬁrmed
Compatible acute illness, plus 1 of the following:
 4 fold rise in Microscopic Agglutination Test (MAT) titre between acute and convalescent serum
Culture* and isolation of pathogenic Leptospira spp. from blood, urine, CSF or tissues
Pathogenic Leptospira spp. DNA detected by Polymerase Chain Reaction (PCR) from blood/blood
derivatives, urine, cerebrospinal ﬂuid, or tissues
Detection of Leptospira spp. in tissue by immunohistochemical techniques
Human acute disease case deﬁnition, probable
Compatible acute illness, plus 1 of the following:
MAT titre 1:400 in single or paired serum samples
Presence of IgM antibodies by enzyme-linked immunosorbent assay (ELISA) or dipstick
Presence of IgM or a fourfold increase in IFA antibody titre in acute and convalescent serum samples
Animal carrier case deﬁnition, conﬁrmed
Clinical signs present or absent, plus  1 of the following:
Culture* and isolation of pathogenic Leptospira spp. from a normally sterile site
Pathogenic Leptospira spp. DNA detected by PCR or real-time PCR (qPCR) from a normally sterile site
Typing of previously isolated strain
Detection of Leptospira spp. in clinical specimens by immunohistochemical techniques
Footnotes
* Culture in any of the following media: Ellinghausen-McCullough-Johnson-Harris (+/- 5’Fluorouracil),
Fletcher, Korthoff, Stuart, Vervoot or Noguchi culture media.
doi:10.1371/journal.pntd.0003899.t002
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Fig 1. PRISMA flowchart. Selection of eligible articles for study inclusion.
doi:10.1371/journal.pntd.0003899.g001
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(44.8%) of 58 countries included in the UNmacro-geographical definition of the African conti-
nent (Fig 2) [27]. Major risks of bias identified in eligible studies were selection bias, attrition
bias in studies that relied on paired serology (MAT) for confirmatory diagnosis, and reporting
bias, as descriptions of diagnostic methodology and results were often incomplete.
Acute human leptospirosis studies
Acute human leptospirosis was reported in 46 eligible studies from 18 African countries (Fig 2)
[31–76]. South Africa was the most frequently represented country with a total of six articles
[43, 47, 54, 57, 65, 71], followed by Egypt [45, 55, 56, 58, 59] and Kenya [31, 37–39, 42] with
five included articles. Twenty-one articles described acute human leptospirosis in hospital or
health centre-based cohort studies (Table 3). Five articles described data from passive popula-
tion-based surveillance [35, 41, 64, 70, 73], and two articles described active case-finding in the
setting of an outbreak of acute febrile illness [31, 72]. Non-specific febrile illness was the most
common clinical criteria described for cohort or surveillance study inclusion. Jaundice was
stated as a primary inclusion criterion in three hospital-based cohort studies [44, 61, 66]. Hae-
moglobinuria was stated as the only inclusion criterion in one study conducted in the Demo-
cratic Republic of the Congo (DRC) [40].
Fig 2. Geographic distribution of acute human leptospirosis and confirmed animal Leptospira spp. infection in Africa.
doi:10.1371/journal.pntd.0003899.g002
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Diagnostic methodologies for human studies
The majority of studies (n = 41/46) used microscopic agglutination test (MAT) as a primary
method to diagnose human cases of acute leptospirosis. IgM enzyme linked immunosorbent
assay (ELISA) testing was the only diagnostic method used in three studies [31, 40, 63], but was
more commonly used as part of a multi-faceted diagnostic approach (n = 6/46) [44, 45, 58, 64,
68, 73]. Fifteen (32 6%) of 46 eligible human studies demonstrated leptospirosis infection by
blood culture in combination with serological diagnostics [34, 35, 37–39, 41, 44, 54–56, 58, 59,
64, 69], and nine (19 5%) studies also used PCR detection as well as culture and serology [34,
35, 41, 56, 58, 59, 64, 70, 73]. Genetic targets for diagnostic PCR assays included lbf1,[34, 35]
lipL32 [34, 35], rrs [34, 35, 70], and ligA [58, 59]. No culture-independent genetic typing of Lep-
tospira spp. was reported in any included human studies.
Human leptospirosis prevalence
Leptospirosis prevalence varied by study design and inclusion criteria (Table 3). In hospital-
based prospective cohort studies in mainland Africa that enrolled patients with non-specific
febrile illness and usedMAT serology for diagnosis of acute leptospirosis with or without adjunct
diagnostics, prevalence ranged from 2 3% to 19 8% (n = 11; number of patients: median = 166;
range = 39–2441) [33, 36–39, 42, 44, 45, 55, 58, 68]. A hospital-based prospective cohort study of
febrile patients in Mayotte that diagnosed acute leptospirosis by PCR and culture without serol-
ogy reported a prevalence of 13 7% (number of patients = 2523) [34]. In hospital-based cohort
studies that used jaundice as the main study enrolment criterion, prevalence of acute leptospiro-
sis ranged from 2 0% to 16 1% (n = 3; number of patients: median = 102; range = 99–392) [44–
46]. Acute leptospirosis was also reported in one patient (2 3%) of 38 with haemoglobinuria [40],
three patients (25 0%) of 12 involved in an outbreak of acute febrile disease in a pastoralist com-
munity in northern Kenya [31], and eight patients (9 8%) of 82 involved in an outbreak of acute
pulmonary disease (pneumonia) in a mining camp in DRC [72].
Human leptospirosis incidence
Incidence estimates were calculated in five population-based surveillance studies [35, 41, 64,
70, 73] and two hospital-based prospective cohort studies [63, 74]. The only estimate of inci-
dence from mainland Africa came from northern Tanzania, where regional incidence of 75 to
102 cases per 100,000 people per year was reported. This estimate was obtained by combining
data on leptospirosis prevalence from hospital-based surveillance of febrile disease with multi-
pliers derived from a population-based health-care utilisation survey [74]. For the Indian
Ocean islands, incidence estimates were available for the Seychelles where the average annual
incidence was estimated as 60 to101 cases per 100,000 [63, 70]; Réunion where the average
annual incidence reported in three studies using a variety of data sources ranged from 3 1 to 12
0 cases per 100,000 [41, 64, 73] and Mayotte, where the average annual incidence calculated
from cases identified through four years of active hospital-based surveillance between 2007 and
2010 was reported as 25 cases per 100,000 [35].
Human case reports
Sixteen case reports describing acute leptospirosis in a total of 34 individuals were considered
eligible for study inclusion. A wide range of clinical manifestations were reported including
febrile illness, jaundice, meningitis, and acute respiratory distress syndrome. Case reports
described confirmed or probable acute leptospirosis in patients in South Africa (n = 6) [43, 47,
54, 57, 65, 71], Gabon (n = 3) [48, 62, 76], Morocco (n = 3) [50, 52, 53], Algeria (n = 1) [32],
Epidemiology of Leptospirosis in Africa
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Table 3. Summary of eligible cohort and surveillance studies reporting human acute leptospirosis in Africa, 1930–2014.
Citation Study
year(s)
Country Setting and study
design
Inclusion and exclusion criteria Diagnostic tests Number
enrolled
Total
number of
eligible
cases*
(%)
No. of eligible
cases:
conﬁrmed &
probable *
Van Riel et al
[69]
1952–
54
Democratic
Republic of
Congo (DRC)
Hospital;
retrospective
cohort
Clinical suspicion of leptospirosis Culture (blood) in
Vervoort-Korthoff
media;
Agglutination-lysis
(MAT)
45 27 (60 0%) 5 conﬁrmed, 22
probable
Kolochine-
Erber &
Brygoo[49]
1954–
55
Madagascar Undeﬁned;
prospective cohort
Clinical suspicion of leptospirosis Agglutination-lysis
(MAT)
40 1 (2 5%) 1 probable
Forrester et al
[42]
1961–
62
Kenya Hospital;
prospective cohort
Febrile illness unexplained by
malaria, dysentery or pneumonia.
MAT 67 6 (9 0%) All probable
Payet et al
[61]
1964–
65
Senegal Hospital;
prospective cohort
Clinical suspicion of leptospirosis;
mostly deﬁned by jaundice
Agglutination-lysis
(MAT)
53 3 (5 7%) 2 conﬁrmed, 1
probable
Silverie et al
[67]
1966–
67
Madagascar Undeﬁned;
prospective cohort
Clinical suspicion of leptospirosis Agglutination-lysis
(MAT)
65 7 (10 8%) All probable
De Geus et al
[37]
1967 Kenya Hospital and health
centre; prospective
cohort
Febrile illness (temperature  38°C)
without obvious cause; negative
malaria smear or no response to anti-
malarial treatment
Culture (blood) in
Fletcher’s and
Cox’s media; MAT
39 7 (17 9%) 6 conﬁrmed, 1
probable
Sankale et al
[66]
1967–
72
Senegal Hospital;
retrospective
cohort
Inpatients with serum samples tested
for leptospirosis
Serum agglutination
(MAT)
134 3 (2 2%) All conﬁrmed
De Geus et al
[39]
1968–
69
Kenya Hospital outpatient
department and
health centre;
prospective cohort
Febrile illness (temperature  38.3°C)
without obvious cause; negative
malaria smear or no response to anti-
malarial treatment a
Culture (blood) in
Fletcher’s media;
MAT
91 10 (11 0%) All conﬁrmed
De Geus et al
[38]
1969 Kenya Hospital &
outpatient
department;
prospective cohort
& case-ﬁnding
survey b
Febrile illness (temperature  38.3°C)
without obvious cause; negative
malaria smear or no response to anti-
malarial treatment
Culture (blood) in
Fletcher’s media;
MAT c
281 9 (3 2%) All conﬁrmed
Kinebuchi
et al[46]
NA Ghana Hospital;
prospective cohort
Clinical suspicion of leptospirosis,
mostly deﬁned by hepatitis or
jaundice
Culture (blood) in
Korthof’s media;
MAT
99 13 (13 1%) 7 conﬁrmed,6
probable
Hogerzeil
et al[44]
1981–
82
Ghana Hospital outpatient
department;
prospective cohort
Group 1: Fever without obvious
cause and/or any of the following;
jaundice, muscle pains, meningism,
conjunctival injection, albuminuria;
negative malaria smear
Culture (blood and
urine) in Fletcher’s
or Ellinghausen-
McCullough-
Johnson-Harris
Group 1:
88
Group 1: 4
(4 5%)
Group 1: 3
conﬁrmed; 1
probable
Group 2: Jaundice Group 2:
102
Group 2: 2
(2 0%)
Group 2: All
conﬁrmed
Delacollette
et al[40]
1985–
86
DRC Hospital;
prospective cohort
Inpatients with black or red urine with
conﬁrmed haemoglobinuria
ELISA (unspeciﬁed) 38 1 (2 6%) All probable
Pinn[63] 1988–
90
Seychelles Hospital;
prospective cohort
Inpatients with clinical diagnosis of
leptospirosis d
IgM ELISA 80 58 (72 5%) All probable
Collares-
Pereira et al
[36]
1993 Mozambique Hospital outpatient
department;
prospective cohort
Outpatients aged 18–50 years with
acute febrile illness without obvious
cause; negative malaria smear.
MAT 43 1 (2 3%) 1 probable
Yersin et al
[70]
1995–
96
Seychelles Nationwide health
care providers;
Prospective
population-based
surveillance
Fever or any of the following without
obvious cause: myalgia, liver
tenderness, jaundice, acute renal
failure, bleeding tendency,
radiographic lung inﬁltrates, or
meningism
MAT; PCR (rrs) 125 75 (60 0%) All conﬁrmed
Desvars et al
[41]
1998–
2008
Réunion Hospital;
retrospective
population-based
surveillance
Cases voluntarily reported to Centre
National de References de
Leptospiroses (Paris, France)
Culture (blood),
media not speciﬁed;
MAT; PCR (target
not speciﬁed)
NA 613 cases All probable**
(Continued)
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Table 3. (Continued)
Citation Study
year(s)
Country Setting and study
design
Inclusion and exclusion criteria Diagnostic tests Number
enrolled
Total
number of
eligible
cases*
(%)
No. of eligible
cases:
conﬁrmed &
probable *
Ismail et al
[45]
1999–
2003
Egypt Hospital;
retrospective
cohort
Group 1: fever (temperature 38°C)
for 3 days in the absence of
diarrhoea, pneumonia, typhoid fever,
brucellosis or established fever of
unknown origin.
IgM ELISA; MAT Group
1:886 e
Group 1:
141 (15
9%)
All probable**
Group 2: acute hepatitis deﬁned as
signs of acute jaundice.
Group 2:
392 f
Group 2:
63 (16 1%)
Renault et al
[64]
2004–
08
Réunion Hospital;
retrospective
population-based
surveillance
Hospitalised cases of leptospirosis
cases in Réunion reported to the
Regional Directorate for Health and
Social Affairs/Regional Health
Agency of the Indian Ocean.
Conﬁrmed cases:
Culture (not
speciﬁed), MAT or
PCR (target not
speciﬁed)
240 160 (66
7%)
All probable**
Possible cases: IgM
ELISA; MAT
titre  1:50
Pages et al
[73]
2004–
12
Réunion Population-based
surveillance
Conﬁrmed or probable cases of
leptospirosis in Réunion residents
reported to the health watch platform
of the French Regional Health
Agency for the Indian Ocean.
Conﬁrmed cases:
Culture (not
speciﬁed), MAT or
PCR (target not
speciﬁed)
NA 405 cases All probable**
Possible cases: IgM
ELISA.
Ari et al[31] 2005 Kenya Community;
prospective case-
ﬁndingg
Community members with new onset
febrile illness (temperature not
deﬁned) or joint pains
IgM ELISA 12 3 (25 0%) All probable
Bertherat
et al[72]
2005 DRC Community;
retrospective case
ﬁnding
Acute & convalescent patients with
respiratory disease in a mining camp
MAT 82 8 (9 8%) All probable
Parker et al
[58]
2005–
2006
Egypt Hospital;
prospective cohort
Fever  2 days or admission
temperature 38.5°C, aged  4
years without obvious cause of fever,
such as diarrhoea, pneumonia, or
clinical diagnosis of typhoid fever or
brucellosis.
Culture (blood) in
EMJH; MAT; PCR;
IgM ELISA
981 194 (19
8%)
45 conﬁrmed;
149 probable
Parker et al
[59]
2005–
2006
Egypt Hospital;
prospective cohort
Fever  2 days or admission
temperature 38.5°C, aged  4
years without obvious cause of fever;
with laboratory evidence of co-
infection with Leptospira, Rickettsia
typhi, Brucella, or Salmonella enterica
serogroup Typhi
Culture (blood) in
EMJH; MAT; PCR
(ligA)
187 h 152 (81
3%)
All conﬁrmed
Murray et al
[55, 56]
2005–
2007
Egypt Hospital;
prospective cohort
Fever; aged  4 years without
obvious cause of fever, such as
diarrhoea, pneumonia, or clinical
diagnosis of typhoid fever or
brucellosis.
Culture (blood) in
EMJH media; MAT;
PCR (ligA)
2,441 98 (4 0%) All probable**
Tagoe et al
[68]
NA Ghana Hospital;
prospective cohort
Fever  2 days and temperature
38.0°C; aged  4 years without
obvious cause of fever
IgM ELISA; MAT 166 13 (7 8%) All probable
Biggs et al
[33, 74]
2007–
08
Tanzania Hospital;
prospective cohort
Inpatients aged 13 years with fever
(38.0°C oral) or inpatients aged 2
months to 12 years with history of
fever within 48 hours or admission
temperature 37.5ºC axillary
38.0ºC rectal.
MAT 831 70 (8 4%); 40 conﬁrmed,
30 probable
Bourhy et al
[35]
2007–
08
Mayotte Undeﬁned;
prospective cohort
Fever (temperature 38°C) for
7days and headache and/or
myalgia
Culture (blood) in
EMJH media; PCR
(rrs)
388 53 (13
7%),
All conﬁrmed
(Continued)
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Mali (n = 1) [51], Réunion (n = 1) [75], and Senegal (n = 1) [60]. With the exception of
Réunion and Senegal, case reports were the only eligible data on acute human leptospirosis
from these countries.
Animal Leptospira infection studies
Naturally occurring Leptospira spp. infection in animal hosts was reported by 51 eligible cita-
tions describing studies performed in 17 African countries (Fig 2) [77–127]. South Africa [84,
100, 101, 104, 117, 120–122] and Zimbabwe [83, 93–99] were the most frequently represented
countries with a total of eight included articles per country, followed by Tanzania with seven
articles [106, 110–112, 114–116]. Wild animal surveys were most commonly described
(n = 21/51) followed by strain typing of Leptospira spp. previously isolated from naturally
infected animal hosts (n = 13/51), livestock disease outbreaks (n = 7/51) and abattoir surveys
(n = 7/51). Four citations (n = 4/51) reported human leptospirosis outbreaks as the inciting
cause for investigations into animal carrier status [86, 109, 117, 123].
Carrier animal species
Leptospira spp. infection was demonstrated in a wide range of animal hosts (S1 Table), includ-
ing cattle (Bos spp.) [85, 87, 89–91, 93–102, 111, 114, 119, 121, 127]; pigs (Sus scrofa domestica)
[78, 79, 84, 85, 100, 104, 106, 122]; goats (Capra aegagrus hircus) [85]; Rusa deer (Rusa timor-
ensis) [85]; dogs (Canis lupis familiaris) [85, 113, 116]; cats (Felis catus) [85, 113, 116]; rodents
including the African grass rat (Arvicanthus niloticus) [87, 88], African giant pouched rat
Table 3. (Continued)
Citation Study
year(s)
Country Setting and study
design
Inclusion and exclusion criteria Diagnostic tests Number
enrolled
Total
number of
eligible
cases*
(%)
No. of eligible
cases:
conﬁrmed &
probable *
Bourhy et al
[34]
2007–
2010
Mayotte k Undeﬁned;
population-based
surveillance
Patients for which a blood sample
was submitted for leptospirosis
diagnosis to the Hospital Centre of
Mayotte
Culture (blood) in
EMJH media; PCR
(lbf1, lipL32, rrs)
2,523 198 (7 8%) All conﬁrmed
Footnotes
*Figures reported here are based on the number of reported acute leptospirosis cases that met our review case deﬁnitions (see Table 1 for case
deﬁnitions) and therefore may vary from the values reported in the original citations.
** All cases met probable case deﬁnitions. An unspeciﬁed proportion of positive cases also met the case deﬁnition for conﬁrmed cases but exact
numbers could not be determined from the available data.
a Patients who refused hospital admission were not investigated.
b Methods describe a change to a case-ﬁnding survey partway through the study, but full details not available
c MAT performed in a subset of participants only
d Clinical diagnosis deﬁned as 3 of the following: headache or fever (temperature not deﬁned), evidence of liver inﬂammation (deﬁned as jaundice,
tender liver, and/or abnormal liver function tests), evidence of renal inﬂammation (haematuria and/or abnormal renal function), or evidence of muscle
inﬂammation (tenderness and/or elevated creatine phosphokinase)
e All tested negative for Salmonella enterica serovar Typhi, Brucella spp., and Rickettsia spp.
f All tested negative for Hepatitis A, B, and C.
g In setting of outbreak of acute febrile illness in a well-deﬁned population
h 187 patients were diagnosed with selected co-infections out of a total cohort of 1510 patients with non-speciﬁc febrile illness.
ϖ Taken  9 days of onset of illness
k Also report two imported cases from Comoros and Madagascar respectively
doi:10.1371/journal.pntd.0003899.t003
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(Cricetomys gambianus) [110, 112], lesser tufted-tailed rat (Eliurus minor) [125], fringe-tailed
Gerbil (Gerbilliscus robustus) [77, 88], rusty-bellied brush-furred rat (Lophuromus sikapusi)
[109], multimammate mouse (Mastomys sp.) [83, 87, 103, 115], house mouse (Mus musculus)
[80, 81, 83, 85, 118, 120, 124], brown rat (Rattus norvegicus) [82, 85, 103, 108, 117, 118, 120,
124], black rat (Rattus rattus) [83, 85, 86, 92, 103, 118, 120, 124], South African pouched mouse
(Saccostomys campestris) [88]; and a range of other free-living mammal species including shrews
(Crocidura spp. and Suncus murinus) [86, 103, 115, 118]; mongoose (Herpestes ichneumon,
Mungo mungo and Paracynictic selousi) [80, 105]; Egyptian fox (Vulpes vulpes niloticus) [80];
shrew tenrecs (Microgale cowani,Microgale dobsoni,Microgale longicaudata,Microgale majori,
Microgale principula) [125]; streaked tenrecs (Hemicentetes nigriceps,Hemicentetes semispinosus)
[125]; and various bat species (Chaerephon pusillus,Miniopterus gleni,Miniopterus goudoti,
Miniopterus griffithsi,Miniopterus griveaudi,Miniopterus mahafaliensis,Miniopterus majori,
Miniopterus soroculus,Mormopterus francoismoutoui,Mormopterus jugularis,Mytotis goudoti,
Otomops madagascariensis, Rousettus obliviosus, Triaenops furculus, Triaenops menamena) [107,
125]. Studies demonstrating infection in cattle were most common (n = 20/51) followed by pigs
(n = 8/51), black rats (n = 8/51), brown rats (n = 7/51) and house mice (n = 7/51).
Diagnostic methodologies for animal studies
Culture and isolation was the most common detection method for Leptospira infection in animal
studies (n = 43/51). PCR assays were used to demonstrate Leptospira spp. infection in 13 (25 5%)
out of 51 studies [85, 86, 92, 103, 105, 107, 115, 118, 120, 123–126]. In three studies, culture and
PCR were used in combination to determine infection status [92, 115, 118]. As with human studies,
a variety of genetic targets were used in PCR assays to detect pathogenic leptospiral DNA, includ-
ing lipL32/hap1, [85, 86, 118], secY, [103], rrl [105], and rrs [107, 115, 120]. PCR was predomi-
nantly used to demonstrate Leptospira spp. infection in rodents and wild animal species. Only one
study in Réunion also used PCR assays to demonstrate infection in domestic animals [85].
Prevalence in animal populations
Leptospira infection prevalence varied widely by target animal species and diagnostic methodol-
ogy (S1 Table). Studies that used PCR diagnosis reported higher infection prevalence than stud-
ies that relied on Leptospira culture and isolation. Overall Leptospira infection prevalence
reported in black rats tested by PCR ranged from 11 0% to 65 8% (n = 6; number of animals:
median = 79, range = 33–141) [85, 86, 92, 103, 118, 124]. In two studies where black rats were
tested by both PCR and culture, prevalence was higher by PCR (11 0%, n = 100; and 28.7%,
n = 94) than by culture (4 0% and 3 2%) in Egypt [92], and Madagascar respectively [118]. A
similar relationship was observed in brown rats, house mice and Asian house shrews tested in
Madagascar [118]. Cattle and brown rats were the most common species tested by culture.
Prevalence in brown rats ranged from 2 7% to 8 5% by culture (n = 3; number of animals:
median = 256, range = 130–919) [82, 108, 117] but was considerably higher in three studies that
used PCR to detect infection (10 0% to 4 7%; number of animals: median = 11, range = 10–96)
[103, 118, 124]. In four abattoir-based surveillance studies of cattle from Egypt, Nigeria and
Zimbabwe [87, 89, 93, 127], renal Leptospira spp. carrier status was detected by culture in 1 1%
to 10 4% of sampled animals (number of animals: median = 480, range = 74–625), compared to
18 2% (number of animals = 77) in a single PCR-based study fromMayotte [85].
Serological typing of infecting leptospires in humans and animals
Serological typing of Leptospira spp. isolates from patients with acute leptospirosis was
described in cohort studies conducted in the DRC [69], Egypt [55, 56], Ghana [44], Kenya
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[37–39] and Mayotte [34, 35], and in a case report from South Africa [54]. Isolates belonging
to 15 serogroups were reported (Table 4). Mini and Icterohaemorrhagiae were the most com-
monly reported serogroups. Isolates that were equally cross-reactive with representative sero-
vars from more than one serogroup (Mini/Hebdomadis and Pyrogenes/Ballum) were reported
by two studies in Mayotte [34, 35]. In animal studies, isolates belonging to 12 serogroups were
reported from 33 articles. At least one animal host was identified within Africa for 11 (73 3%)
out of the 15 human-infecting serogroups identified in this review (Table 4). However, only six
of these serogroups were detected in human and animal populations from the same country.
These were serogroup Autumnalis in Kenya [39, 88]; and serogroups Canicola [56, 92, 113],
Grippotyphosa [56, 80, 81, 92], Icterohaemorrhagiae [55, 80, 92, 127], Pomona [55, 56, 127]
and Pyrogenes [56, 92] in Egypt. Serogroups associated with human febrile illness were fre-
quently isolated from multiple animal hosts. One of the most commonly reported serogroups
isolated from patients in Africa, serogroup Icterohaemorrhagiae, was isolated from cattle,
brown rats, Egyptian mongoose and an Egyptian fox. Cattle were identified as carrier hosts for
the widest range of Leptospira serogroups (n = 9) but several other animal species, such as Afri-
can grass rats and black rats were also identified as carrier hosts for multiple serogroups.
Genetic typing of leptospires in humans and animals
Leptospira spp. isolated from human patients with acute leptospirosis belonged to five patho-
genic Leptospira species (Table 5). L. interrogans was the most widespread and common
species reported in either human or animal studies in Africa. Multiple animal hosts were iden-
tified for L. interrogans as well as the other common species, L. borgpetersenii and L. kirschneri,
from a variety of countries. The widest diversity in Leptospira spp. was reported from two Ken-
yan studies of acute human leptospirosis, where isolates belonging to five species were identi-
fied (L. borgpetersenii, L. interrogans, L. kirschneri, L. noguchii and L. santarosai) [38, 39].
However, L. noguchii and L. santarosai were not detected in any other studies. Four Leptospira
species: L. borgpetersenii, L. borgpetersenii-like, L. interrogans and L. kirschneri; were identified
in two human studies on Mayotte, as well as by a concurrent study of black rats performed dur-
ing the same period [34, 35, 86]. Divergent Leptospira spp. described as L. borgpetersenii-like
and L. borgpetersenii Group B were detected in human and animal studies respectively in
Mayotte, and in a study of indigenous small mammals in Madagascar [34, 35, 86, 125].
Sequencing and alignment of the atypical isolates from rat kidneys in Mayotte [86] showed
perfect identity with isolates derived from people [35].
Discussion
This systematic review is the first to synthesize and compile data on the epidemiology of acute
human leptospirosis and pathogenic Leptospira spp. infection in animals in Africa. Leptospiro-
sis remains amongst the neglected tropical diseases and is frequently overlooked in research
priorities for African countries [1]. Yet, through this systematic review we have revealed a
wealth of scientific evidence for acute human infection demonstrating that acute leptospirosis
is an important cause of febrile illness in hospital patients across the African continent. Few
studies providing population-level data on leptospirosis incidence in Africa were identified but
available estimates indicate that the disease incidence is high in both island and mainland pop-
ulations. In reports of human disease and animal infection, three predominant species, Leptos-
pira borgpetersenii, L. interrogans and L. kirschneri, and a variety of Leptospira serogroups were
diagnosed. Leptospira infection was reported in a wide range of domestic and wild animal spe-
cies from across Africa but studies linking data on animal infections with studies of acute
human disease were rare.
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Table 4. Serogroups of Leptospira isolated from cases of acute human leptospirosis and animal carrier hosts by country.
Human
Studies
Animal Studies
Serogroup Country Host species Country
Australis Kenya[39] African grass rat (Arvicanthus niloticus) Nigeria[87]
Cattle (Bos spp.) Zimbabwe[93]
Autumnalis Kenya[39] African grass rat (Arvicanthus niloticus) Kenya[88]
Ballum Not reported African giant pouched rat (Cricetomys
gambianus)
Tanzania[110, 112]
African grass rat (Arvicanthus niloticus) Nigeria[87]
South African pouched mouse (Saccostomys
campestris)
Kenya[88]
Bataviae Egypt[55, 56] Cattle (Bos spp.) Zimbabwe[93, 94]
Rusty-bellied brush-furred rat (Lophuromys
sikapusi)
Cameroon[109]
Canicola Egypt[56] Black rat (Rattus rattus) Egypt[92], Madagascar[118]
Kenya[39] Brown rat (Rattus norvegicus) Madagascar[118]
South Africa
[54]
Dogs (Canis lupus familiaris) Egypt[113]
Pigs (Sus scrofa domesticus) South Africa[122]
Djasiman Ghana[44] Not reported
Grippotyphosa DRC[69] Black rat (Rattus rattus) Egypt[92]
Egypt[56] Cattle (Bos spp.) Kenya[119] Zimbabwe[93, 97]
Mayotte [34,
35]
House mouse (Mus musculus) Egypt[80, 81]
Hebdomadis DRC[69] Cattle (Bos spp.) Zimbabwe[93, 99]
Kenya[37–39]
Icterohaemorrhagiae Egypt[55, 56] Brown rat (Rattus norvegicus) South Africa[117], Tunisia[108]
Ghana[44] Cattle (Bos spp.) Egypt[127], Tanzania[114], Zimbabwe[93, 95]
Kenya[37, 38] Egyptian fox (Vulpes vulpes niloticus) Egypt[80]
Egyptian mongoose (Herpestes ichneumon) Egypt[80]
Mini Mayotte[34,
35]
Not reported
Pomona Egypt[55, 56] Cattle (Bos spp.) Botswana[102], Egypt[127], South Africa[100, 101],
Zimbabwe[93, 97]
Mayotte[35] Pigs (Sus scrofa domesticus) South Africa[84, 100, 104]
Pyrogenes Egypt[56] Black rat (Rattus rattus) Egypt[92]
Kenya[39] Cattle (Bos spp.) Nigeria[87, 89–91], Zimbabwe[93, 98]
Mayotte[34,
35]
Sejroe Not reported Black rat (Rattus rattus) Egypt[92]
Cattle (Bos spp.) South Africa[121], Zimbabwe[93]
Tarassovi DRC[69] Cattle (Bos spp.) Zimbabwe[93, 96]
Fringe-tailed gerbil (Gerbilliscus robustus) Kenya[88]
Pigs (Sus scrofa domesticus) Tunisia[78, 79]
Wolﬁi Egypt[56] Not reported
Mini/Hebdomadis* Mayotte[34,
35]
Not reported
Pyrogenes/Ballum* Mayotte[35] Not reported
Footnotes
* Cross-reactive isolates
doi:10.1371/journal.pntd.0003899.t004
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Table 5. Leptospira speciesa reported in acute human leptospirosis and animal carrier hosts by African country.
Human
Studies
Animal Studies
Species Country Host species Country
L. borgpetersenii Kenya[38, 39] African grass rat (Arvicanthus niloticus) Nigeria[87]
Mayotte[34,
35]
Black rat (Rattus rattus) Benin[103], Egypt[92], Mayotte[86]
Cattle (Bos spp.) Nigeria[87, 89–91], South Africa[121], Zimbabwe[98]
Comoro rousette (Rousettus oblivious) Comoros[107]
Fringe-tailed gerbil (Gerbilliscus robusta) Kenya[88]
Giant African pouched rat (Cricetomys gambianus) Tanzania[112]
Lesser tufted-tailed rat (Eliurus minor) Madagascar[125]
Long-winged bats (Miniopterus spp)b Madagascar[125]
Madagascar free-tailed bat (Otomops
madagascariensis)
Madagascar[107]
Multimammate mouse (Mastomys sp.) Benin[103]
Pigs (Sus scrofa domesticus) Tunisia[78]
Shrew tenrecs (Microgale spp.)c Madagascar[125]
South African pouched mouse (Saccostomys
campestris)
Kenya[88]
L. borgpetersenii-
liked
Mayotte[35] Black rat (Rattus rattus) Mayotte[86]
Shrew tenrec (Microgale cowani, Microgale dobsoni) Madagascar[125]
L. interrogans Egypt[56] African giant shrew (Crocidura oliveri) Benin[103]
Ghana[44] African grass rat (Arvicanthus niloticus) Nigeria[87]
Kenya[38, 39] Asian house shrew (Suncus murinus) Madagascar[118]
Mayotte[34,
35]
Banded mongoose (Mungo mungo) Botswana[105]
Black rat (Rattus rattus) Egypt[92], Mayotte[86], Madagascar[118]
Brown rat (Rattus norvegicus) Benin[103], Madagascar[118]
Cattle (Bos spp.) Botswana[102], Nigeria[87], South Africa[101],
Zimbabwe[94]
Comoro rousette (Rousettus oblivious) Comoros[107]
House mouse (Mus musculus) Kenya[124], Madagascar[118]
Pigs (Sus scrofa domesticus) South Africa[104, 122]
Rusty-bellied brush-furred rat (Lophuromys sikapusi) Cameroon[109]
L. kirschneri Egypt[56] African grass rat (Arvicanthus niloticus) Kenya[88]
Kenya[39] Black rat (Rattus rattus) Mayotte[86]
Mayotte[34,
35]
Cattle (Bos spp.) Kenya[119], Tanzania[114], Zimbabwe[97]
House mouse (Mus musculus) Kenya[124]
Shrew (Crocidura spp.) Benin[103]
Streaked tenrec (Hemicentetes nigriceps, H.
semispinosus)
Madagascar[125]
Footnotes
a methodology includes genetic typing of isolates, DNA sequencing following PCR detection, extrapolation of serovar data with species determined by
reference to KIT Leptospira library.
b Miniopterus spp. include Miniopterus gleni, Miniopterus goudoti, Miniopterus grifﬁthsi, Miniopterus mahafaliensis, Miniopterus majori, Miniopterus
soroculus
c Microgale spp. include Microgale longicaudata, Microgale majori, Microgale principula
d Described as L. borgpetersenii-like,[35] L. borgpetersenii Group B[86] and recently re-classiﬁed as L. mayottensis[134]
doi:10.1371/journal.pntd.0003899.t005
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Acute leptospirosis was diagnosed in up to 19 8% of inpatients with non-specific febrile ill-
ness in hospital-based cohort studies conducted in several countries identified by this review.
In sub-Saharan Africa, recent studies have highlighted that clinical over-diagnosis of malaria
may conceal other aetiologies of febrile illness [20, 128]. Consistent with findings in other
resource-limited tropical settings (e.g. South America [15, 129] and South-East Asia [130–
132]), the evidence synthesised here demonstrates that acute leptospirosis infection is geo-
graphically widespread across the continent and should be considered as an important differ-
ential diagnosis for non-specific febrile illness in Africa.
Few estimates of leptospirosis incidence in Africa were identified by our review, revealing a
key gap in research and surveillance outputs to date. The majority of incidence estimates iden-
tified came from the Indian Ocean islands where reports of annual incidence ranged from 3 1
to 101 cases per 100,000 people. In the African continent, the western Indian Ocean Islands
appear to be the best-characterised region with regards to the human leptospirosis burden, pos-
sibly as a consequence of greater access to public health laboratories through French Territorial
links [133]. We identified only one report of annual leptospirosis incidence from mainland
Africa. This estimate of 75 to 102 cases per 100,000 people [74] was calculated from Tanzanian
hospital-based surveillance data and is consistent with the WHO leptospirosis burden epidemi-
ology reference group (LERG) predicted median African incidence of 95 5 cases per 100,000
[7]. At present, given the lack of population level data highlighted by LERG and by this review,
estimates of the incidence of leptospirosis in Africa should be interpreted with care. However
the data that are available from the continent indicate that the overall leptospirosis burden is
likely to be high relative to other global regions. If the incidence figures identified by this review
are close to the true burden of disease, up to 750,000 people in Africa will develop acute lepto-
spirosis each year, representing a substantial disease burden that would far exceed current
worldwide estimates (500,000 annual cases worldwide) [23].
Our review has revealed three predominant Leptospira species and a considerable diversity
in reported pathogenic Leptospira serogroups in people and animals across the continent. Ani-
mal hosts, including livestock and invasive and indigenous rodent species, were reported for
the majority of species and serogroups detected in human cases. However, there was poor geo-
graphical overlap in serogroup reporting between human and animal studies. Based on the
findings of this review, we suggest that the major animal hosts of human-infecting serovars
may vary across Africa and that both livestock and rodents may play important roles in human
disease transmission. Few data were identified that described Leptospira spp. diversity in
human cases and animal populations from the same country, and few studies attempted to link
data on acute human leptospirosis with evidence of Leptospira infection in local animal popula-
tions. Studies on the Indian Ocean Islands of Mayotte and Madagascar were the exception to
this. Isolates with unusual patterns of genetic and serological diversity, recently reclassified as a
new pathogenic species Leptospira mayottensis [134], were detected from both human and
black rat infections, implicating the black rat as the source of these human infections [35, 86].
These studies demonstrate the value of integrated human and animal research to identify
sources and transmission routes of human leptospirosis, which can in turn help prioritise
investment in disease prevention and control efforts.
The data included in this review most likely represents only the tip of the leptospirosis ice-
berg in Africa. Underreporting of leptospirosis is thought to be substantial and an overall lack
of awareness about the disease and poor accessibility of diagnostic facilities are likely to con-
tribute to this underreporting in Africa populations [135–137]. Patterns in reporting character-
istics such as over-representation of study areas with greater research infrastructure, logistical
connections or prior knowledge of a disease burden may also have resulted in reporting bias,
particularly in assessing the geographic distribution of reports. We observed patient selection
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bias in some human studies, which limited the usefulness of reported prevalence data from
these sources. Methodological limitations identified in this review include the use of the broad
geographical search term ‘Africa’ rather than individual country names in our initial database
searches. This approach may have missed eligible citations that are not indexed to the term
‘Africa’ in our selected databases. Our inclusion criteria may have created a bias towards more
recent citations because of diagnostic technological advancements since the early era of our
search period. Marked heterogeneity in methods and reporting criteria for serological diagnos-
tic data prevented the meaningful synthesis and analysis of data on the reactive serogroups in
human studies. We chose to include non-English language articles to allow inclusion of articles
published in the colonial era, or in local language journals. Wherever possible, a proficient lan-
guage speaker, in partnership with a study author, performed article translation. However, it is
possible that some eligible studies may have been overlooked due to translation limitations.
Addressing the neglect of leptospirosis in Africa will be a major challenging for the future of
leptospirosis research. Systematic review studies such as this can help to raise awareness of the
human health threat of leptospirosis in Africa among researchers and policy makers. For medi-
cal clinicians, the non-specific presenting signs of acute leptospirosis in patients poses a sub-
stantial diagnostic challenge in developing countries where laboratory capacity rarely exists to
diagnose the infection [18–20]. Hence, increasing clinician awareness and the development of
treatment guidelines for the management of febrile patients should be a priority in resource-
limited settings [138]. Integration of risk factor analysis in human cohort studies of febrile dis-
ease is also strongly advocated and would be a valuable next step in identifying groups at high
risk of infection, and defining important animal to human transmission routes.
Knowledge of reservoir or carrier animal hosts is considered essential to understanding the
epidemiology, transmission and control of leptospirosis in each setting [9, 11], yet our review
has revealed that the linkages between Leptospira infections in people and animals are rarely
addressed in the existing literature. Human and animal Leptospira infections are inextricably
linked, and the multi-host epidemiology of leptospirosis means that there may be many poten-
tial sources of infection in a given setting. In the future, greater emphasis should be placed on
performing multidisciplinary human and animal leptospirosis studies in the same geographical
settings. Connecting investigations of animal reservoir populations with confirmed human
cases would improve our understanding of the role that different animal species play in the
transmission of pathogenic Leptospira serovars in a variety of geographic and environmental
settings [8] [139]. Using an integrated ‘One Health’ approach to explore the relationship
between human and animal Leptospira infection in areas where human disease is identified
would also provide invaluable evidence to quantify the direct and indirect impacts of leptospi-
rosis on human and animal populations in Africa [140, 141].
Control measures to prevent human leptospirosis often focus on rodent hosts of the disease.
However, this review reveals that livestock are also important hosts of Leptospira infection in
Africa, and may play a more substantial role in human disease transmission than is widely rec-
ognised. The clinical and sub-clinical productivity impacts of Leptospira infection in domestic
animal populations in Africa are poorly understood. Around the world, several Leptospira sero-
vars are considered to be of economic importance and cause production losses in a variety of
livestock farming species including cattle, sheep, goats and pigs [17, 100, 142, 143]. More than
300 million of the world’s poorest people live in Africa, and at least 60% of these are in some
part dependent on livestock for their livelihood [144]. Therefore, we consider that evaluating
the impact of Leptospira infection on livestock health and productivity is also an important pri-
ority for prospective research in Africa. In the future, control of Leptospira infection in live-
stock species may have considerable scope to directly and indirectly improve human health
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and well-being in Africa, through reduced human leptospirosis transmission and increased
productivity in livestock that subsistence farming communities [8, 142, 143, 145].
Finally, in 1967, the German leptospirosis researcher Kathe commented that ‘The world
map of leptospirosis is, in fact, the world map of leptospirologists’ [67]. This is particularly true
with regards to Africa. With this systematic review, we have started to outline the map of Afri-
can leptospirosis; it is now time to fill in the gaps.
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